Pedram Sameni
Oct 23, 2013
•
Featured
Patent battles healthy for pharma
The Indian pharma space has seen a number of battles between innovators and generic companies — the Novartis war and Merck-Glenmark being one of the recent ones.
The Indian pharma space has seen a number of battles between innovators and generic companies — the Novartis war and Merck-Glenmark being one of the recent ones.